Comet: Effective, Compact, and Low-Cost Phototherapy to Treat Newborn Jaundice
As part of a suite of jaundice diagnostic and treatment technologies aimed at ending kernicterus, we have developed Comet, an extremely low-cost, high-performance, and compact jaundice treatment device targeted at rural and limited-infrastructure clinics and hospitals in developing countries. Comet integrates low power consumption and high intensity LEDs with a lifespan of 3-5 years to provide phototherapy on par with state-of-the-art devices. However, Comet requires minimal maintenance and is designed to retail at less than $150. In partnership with One Heart World-Wide, we are seeking seed funding to field test Comet in India and Nepal, refine the design for final embodiment, and begin market and delivery development.